Intellia Therapeutics Inc.

Jean-Francois B. Formela founded 7 companies, which include: Translate Bio, Inc., ArQule, Inc. and Adnexus. Currently, he is Chairman for Triplet Therapeutics, Inc. (which he founded) and Partner at Atlas Venture, Inc. Dr. Formela is also Member of Massachusetts General Hospital Clinical Research Program and on the board of 20 other companies.

Dr. Formela previously held the position of Chairman of Zyla Life Sciences, Inc., Chairman of Egalet Ltd., Senior Director-Medical Marketing at Schering-Plough Corp., Director at ArQule, Inc., Director at Arteaus Therapeutics LLC, Independent Director at Translate Bio, Inc. and Director at Adnexus.

Jean-Francois B. Formela received a doctorate from Université de Paris XI Paris Sud and an MBA from The Trustees of Columbia University in The City of New York.